Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Astellas Pharma Inc.
  6. News
  7. All News
    4503   JP3942400007

ASTELLAS PHARMA INC.

(4503)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
All news about ASTELLAS PHARMA INC.
06/21Astellas Pharma to Incur Nearly $196 Million Impairment Loss From Termination..
MT
06/17ASTELLAS PHARMA  : Notice Regarding Impairment Loss Following the Termination of..
PU
06/16ASTELLAS PHARMA  : Transfers Five Legacy Products in Europe, Russia, CIS and Asi..
PU
06/09ASTELLAS PHARMA  : New Research Reflects Astellas' Commitment to Acute Myeloid L..
AQ
06/08Heavyweights pull Nikkei lower, Topix gains on drugmakers' boost
RE
06/07Nikkei falls as market heavyweights offset gains in drugmakers
RE
06/02ASTELLAS PHARMA  : Reviewing capabilities for sustainable growth - Astellas Will..
PU
06/02PRESS RELEASE : MorphoSys to Acquire Constellation -2-
DJ
05/31Japanese shares end lower on profit-booking, drugmakers limit losses
RE
05/30Japanese shares retreat from 3-week high; drugmakers limit losses
RE
05/26Japanese shares fall on profit-taking, pandemic worries
RE
05/20ASTELLAS PHARMA  : and Seagen Announce Updated Results from Two Trials of PADCEV..
AQ
05/19ASTELLAS PHARMA  : Seagen and Astellas Announce Updated Results from Two Trials ..
BU
05/18Astellas to Present Data from Expanding Oncology Portfolio During the 2021 AS..
AQ
05/12ASTELLAS PHARMA  : Notice Regarding Continuation of the Performance-linked Stock..
PU
05/11PRESS RELEASE : AMSilk raises EUR 29M to accelerate commercialization of its hig..
DJ
05/11PRESS RELEASE : MIG portfolio company AMSilk completes EUR29 million financing r..
DJ
05/06ASTELLAS PHARMA  : ' XTANDI (enzalutamide) Approved by European Commission for M..
PU
05/05ASTELLAS PHARMA  : ' XTANDI (enzalutamide) Approved by European Commission for M..
AQ
04/28ASTELLAS PHARMA INC.  : - Notice Regarding Impairment Loss for Investigational G..
AQ
04/28ASTELLAS PHARMA INC.  : - Change of Directors
AQ
04/27PRESS RELEASE : MIG AG records 2020 as the most successful year in its company h..
DJ
04/27ASTELLAS PHARMA  : Change of Directors
PU
04/26ASTELLAS PHARMA  : Notice Regarding Impairment Loss for Investigational Gene The..
PU
04/20ASTELLAS PHARMA  : and Seagen Announce U.S. FDA Acceptance of Two Supplemental B..
AQ
04/20ASTELLAS PHARMA  : and Seagen Announce FDA Acceptance of Two Supplemental Biolog..
PU
04/19SEAGEN  : Astellas' Biologics License Applications for Bladder Cancer Drug Candi..
MT
04/14SHANGHAI STOCK EXCHANGE B SHARES IND : China Opens Innovative Medicines, Medical..
MT
04/13ASTELLAS PHARMA  : Updates 'Contact for Potential Acquisition of ' R&D Programs'..
AQ
04/07PRESS RELEASE  : T-knife Therapeutics Announces the Appointment of Donald Wuchte..
DJ
04/04ASTELLAS PHARMA  : and TOA EIYO Announce Termination of Distribution Agreement
PU
04/01ASTELLAS PHARMA  : Establishes ' Gene Therapies' as its Global Gene Therapy Cent..
AQ
04/01ASTELLAS PHARMA  : and TB Alliance Enter into a New Collaborative Research Agree..
AQ
04/01ASTELLAS PHARMA  : Announces Termination of Co-promotion with Viatris for Lipito..
PU
03/31Astellas Pharma's Anti-Cancer Drug Xospata Meets Primary Endpoint in Phase Th..
MT
03/30ASTELLAS PHARMA INC. : Ex-dividend day for final dividend
FA
03/29ASTELLAS PHARMA  : ' XOSPATA Meets Overall Survival Endpoint in COMMODORE Trial
PU
03/29ASTELLAS PHARMA  : Garners New Indication and New Product Formulation Approvals ..
AQ
03/29ASTELLAS PHARMA INC.  : - European Medicines Agency Accepts Marketing Authorizat..
AQ
03/29ASTELLAS PHARMA  : Receives Positive CHMP Opinion for XTANDI for Patients with M..
AQ
03/29ASTELLAS PHARMA  : Receives Positive CHMP Opinion for XTANDITM for Patients with..
AQ
03/29European Medicines Agency Accepts Astellas Pharma's Marketing Authorization A..
MT
03/26ASTELLAS PHARMA INC.  : - Doshisha University, Wakayama Medical University and A..
AQ
03/26PFIZER  : Astellas Receive Positive Opinion From European Medicines Agency for X..
MT
03/26ASTELLAS PHARMA  : Garners New Indication & New Product Formulation Approvals Fr..
PU
03/25ASTELLAS PHARMA  : Oncology Announces Grand Prize Winner of Fifth Annual C-3 Pri..
AQ
03/24ASTELLAS PHARMA  : Presentation Material for Astellas Rx+ Day(Media Seminar)
PU
03/19ASTELLAS PHARMA  : Efforts against the Spread of the Coronavirus Disease
AQ
03/18Japanese shares jump on Fed's growth projection, Topix at 30-year high
RE
03/12Japan stocks end higher as tech sector back in favour
RE
03/12ASTELLAS PHARMA  : Submits Drug Application for Enfortumab Vedotin in Japan
MT
03/11Japanese shares rise on economic optimism, tech rebound
RE
03/11ASTELLAS PHARMA  : Submits New Drug Application for Enfortumab Vedotin in Japan
PU
03/11Japanese shares end higher as cyclicals rally; heavyweights' decline caps gai..
RE
03/10Japanese shares gain on cyclicals boost, selling in some heavyweights weighs
RE
03/09Japan stocks end higher on hopes of economic rebound
RE
03/08Japanese shares rise amid stock rotation ahead of financial year-end
RE
03/05EDISON INVESTMENT RESEARCH LIMITED : Basilea Pharmaceutica (BSLN): Derazantinib ..
DJ
03/03VIVENDI : The Good Results for 2020 Confirm the -6-
DJ
03/01ASTELLAS PHARMA  : Notice Regarding Continuation of the Performance-linked Stock..
AQ
02/26ASTELLAS PHARMA  : Notice Regarding Continuation of the Performance-linked Stock..
PU
02/24PRESS RELEASE  : Creative Balloons closes EUR15 million growth financing and app..
DJ
02/22ASTELLAS PHARMA  : Announces Positive Topline Results from Two Phase 3 Pivotal G..
AQ
02/19ASTELLAS PHARMA  : and Seagen Announce Submission of Two Supplemental Biologics ..
AQ
02/15SEAGEN  : and Astellas Announce Phase 3 Trial Results Demonstrating Survival Adv..
AQ
02/15ASTELLAS PHARMA  : and Seagen Announce Presentation of Results from PADCEV Pivot..
AQ
02/09Japan shares edge higher driven by Honda's upbeat earnings outlook
RE
02/04ASTELLAS PHARMA  : XOSPATA Receives Conditional Approval by China's National Med..
AQ
02/04ASTELLAS PHARMA  : Announces Management Structure
AQ
02/04PRESS RELEASE : MIG funds increases BioNTech dividend payments to a record EUR60..
DJ
02/01ASTELLAS PHARMA  : Returns Rights to EligardTM in Europe, Middle East, CIS, and ..
AQ
02/01ASTELLAS PHARMA  : Posts Lower Profit in October-December 2020
MT
01/28ASTELLAS PHARMA INC.  : - Result of Open Innovation Challenge 'Astellas Rx+ Heal..
AQ
01/25ASTELLAS PHARMA  : Builds New Manufacturing Lines for Aseptic Drugs at Yaizu Tec..
MT
01/25ASTELLAS PHARMA INC.  : - Establishing New Manufacturing Lines for Aseptic Drug ..
AQ
1  2  3  4  5  6  7  8  9Next
Upcoming event on ASTELLAS PHARMA INC.